NCT00518921 - Capadenoson in Angina Pectoris | Biotech Hunter

Timeline

Start Date

March 31, 2008

Study Completion Date

November 30, 2008

Conditions

Chronic Stable Angina

Interventions

DRUG

Capadenoson (BAY 68-4986)

1mg Capadenoson, double dummy

DRUG

Capadenoson (BAY 68-4986)

2mg Capadenoson, double dummy

DRUG

Capadenoson (BAY 68-4986)

4mg Capadenoson, double dummy

DRUG

Placebo

Placebo, double dummy

Trial Locations (36)

3526

Miskolc

6000

Kecskemét

7624

Pécs

8230

Balatonfüred

8900

Zalaegerszeg

13100

Safed

16132

Genova

27100

Pavia

30174

Mestre

30599

Pilsen

34100

Trieste

38100

Hadera

76100

Rehovot

656 91

Brno

695 26

Hodonín

767 55

Kroměříž

775 20

Olomouc

708 52

Ostrava

158 00

Prague

169 02

Prague

15-276

Bialystok

80-952

Gdansk

81-519

Gdynia

40-635

Katowice

30-501

Krakow

59-220

Legnica

91-347

Lodz

83-200

Starogard Gdański

70-111

Szczecin

03-401

Warsaw

50-420

Wroclaw

50-981

Wroclaw

811 04

Bratislava

813 69

Bratislava

949 01

Nitra

940 34

Nové Zámky